Suppression of TGF<sub>β</sub>and Angiogenesis by Type VII Collagen in Cutaneous SCC

Vera Martins, Matthew Caley, Kate M. Moore, Zsófia Szentpétery, S. Marsh, Dédée F. Murrell, M H Kim, M Avari, John A. McGrath, R. Cerio,

JNCI Journal of the National Cancer Institute · 2015 · 82 citations · 45 references

DOIFull text

Open access

Abstract

Type VII collagen suppresses TGFβ signaling and angiogenesis in cutaneous SCC. Patients with RDEB SCC may benefit from anti-angiogenic therapy.

References

45